虚拟与面对面麻醉术前会诊效果比较:VIRTUAL回顾性队列研究
该回顾性目标试验模拟研究纳入安大略省17 027例≥40岁、ASA≥3级、接受择期非心脏非骨科中高风险手术患者,比较术前60天内虚拟与面对面麻醉会诊。主要结局90天主要并发症或死亡的非劣效性结论不确定(工具变量法adj-OR 1.02,95%CI 0.92-1.13;倾向评分法adj-OR 0.99,95%CI 0.89-1.101),但虚拟会诊在住院时长、费用和DAH90等次要结局上非劣效,且减少碳排放。
要点
- 虚拟术前麻醉会诊对90天主要并发症或死亡的非劣效性结论不确定,需进一步研究。
- 虚拟会诊在住院时长、医疗费用和90天居家存活天数上非劣效。
- 面对面会诊每次约增加8618克二氧化碳排放,虚拟会诊更环保。
核心结论
- 在中高风险非心脏非骨科择期手术前,虚拟与面对面麻醉会诊对90天主要并发症或死亡的非劣效性结论不确定。
- 虚拟会诊在住院时长、医疗费用和DAH90等次要结局上非劣效,并与减少碳排放相关。
研究设计与样本
- 回顾性观察性比较效果研究,采用目标试验模拟框架,使用工具变量和倾向评分方法分析。
- 纳入安大略省2020年10月至2022年3月期间≥40岁、ASA≥3级、接受择期非心脏非骨科中高风险手术并接受术前麻醉会诊的患者17 027例,其中8399例(49.3%)接受虚拟会诊。
主要发现
- 主要结局在虚拟会诊组发生2212例(26.3%),面对面会诊组8628例中发生2147例(24.9%)。
- 工具变量分析显示主要结局adj-OR 1.02(95%CI 0.92-1.13),倾向评分分析adj-OR 0.99(95%CI 0.89-1.101),非劣效性结论不确定。
- 住院时长、医疗费用和DAH90达到非劣效性。
- 面对面会诊每次估计增加8618克二氧化碳排放(标准差17 200克)。
关键数值与推荐
- 非劣效性界值为相对尺度上95%置信区间上限<1.10。
- 主要结局非劣效性未确定:工具变量法adj-OR 1.02(95%CI 0.92-1.13),倾向评分法adj-OR 0.99(95%CI 0.89-1.101)。
- 住院时长、医疗费用和DAH90达到非劣效性。
- 面对面会诊每次估计增加8618克二氧化碳排放(标准差17 200克)。
临床怎么用
- 虚拟术前麻醉会诊可用于中高风险非心脏非骨科择期手术患者,在住院时长、费用和DAH90方面不劣于面对面会诊。
- 鉴于主要并发症或死亡的非劣效性不确定,需结合患者风险进行个体化选择并进一步研究分诊模型。
- 虚拟会诊可减少患者和医疗系统碳足迹。
局限性
- 回顾性观察性设计,尽管采用目标试验模拟和工具变量、倾向评分方法,仍可能存在残余混杂。
- 主要结局非劣效性结论不确定,需进一步研究提高确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Virtual care is increasingly used for preoperative assessment. We aimed to estimate the noninferiority of virtual vs in-person anaesthesiology consultations with respect to 90-day morbidity and mortality in at-risk adults having noncardiac surgery. METHODS: We conducted a retrospective observational comparative effectiveness study using a target trial emulation framework. Eligible participants were aged ≥40 yr, with an ASA physical status ≥3, having elective, noncardiac, non-orthopaedic, moderate- to high-risk surgery, and attended a preoperative anaesthesiology consultation in Ontario, Canada, between October 2020 and March 2022. Exposures were receipt of virtual vs in-person preoperative anaesthesiology consultation in the 60 days preceding surgery. The primary outcome was 90-day major morbidity or mortality (noninferiority margin of upper 95% confidence interval [CI] <1.10 on relative scale). Secondary outcomes included 90-day mortality, length of hospital stay, costs of care, and days alive and at home within 90 days (DAH90). Travel-attributable carbon emissions were also estimated. Analyses used instrumental variable and propensity score methods. RESULTS: Among 17 027 patients, 8399 (49.3%) received a virtual consultation. The primary outcome occurred in 2212 (26.3%) virtual consult patients and 2147 (24.9%) of 8628 in-person consult patients. Primary outcome noninferiority was inconclusive based on both instrumental variable (adjusted odds ratio [adj-OR] 1.02, 95% CI 0.92-1.13) and propensity-score adjusted (adj-OR 0.99, 95% CI 0.89-1.101) analyses. Noninferiority was observed for length of hospital stay, costs of care, and DAH90. In-person care was associated with an estimated increase of 8618 (SD 17 200) g CO2 per visit. CONCLUSIONS: Before moderate-to-high-risk noncardiac, non-orthopaedic elective surgery, the noninferiority of virtual vs in-person anaesthesiology consultation for major morbidity or mortality was inconclusive. Virtual care was noninferior for several secondary outcomes and associated with reduced carbon emissions. Further research is required to refine triage models and increase certainty regarding morbidity.
引用
- Engel J, Berrio M, Hladkowiz E, et al. Comparative effectiveness of virtual versus in-person anaesthesiology consultations: the VIRTUAL retrospective cohort study. Br J Anaesth. 2026. PMID: 42509157. doi:10.1016/j.bja.2026.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。